Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chemoradiotherapy × CNS × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 19 Head & Neck 10 Thoracic 3 Gynecologic 3 Tumor-Agnostic 1 Other neoplasm 1 CNS 1 Breast 1

Conditions

Interventions

Radiotherapy 64 Temozolomide 59 Vincristine 33 Cyclophosphamide 32 Carboplatin 30 Radiosurgery 26 Etoposide 25 Cisplatin 25 Lomustine 24 Magnetic Resonance Spectroscopy 19 Filgrastim 17 Doxorubicin 15 Bevacizumab 15 Radiation 13 Specimen Handling 12 Granulocyte Colony-Stimulating Factor 12 Surgical Procedures, Operative 11 Isotretinoin 11 Melphalan 10 Carmustine 10 Procarbazine 9 Platinum 9 Peripheral Blood Stem Cell Transplantation 9 Chemotherapy, Adjuvant 9 etoposide phosphate 7 Topotecan 7 1,2-diaminocyclohexaneplatinum II citrate 7 sargramostim 6 Thiotepa 6 Radiotherapy, Intensity-Modulated 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02685605 2025-10-14

INTRAGO-II

Universitätsmedizin Mannheim

Phase 3 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡